Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis

被引:4
|
作者
De Veylder, L
Beeckman, T
Beemster, GTS
Krols, L
Terras, P
Landrieu, I
Van der Schueren, E
Maes, S
Naudts, M
Inzé, D
机构
[1] State Univ Ghent VIB, Dept Plantengenet, Vakgrp Mol Genet, B-9000 Ghent, Belgium
[2] CropDesign NV, B-9052 Zwijnaarde, Belgium
[3] Inst Pasteur, Inst Biol, CNRS, Unite Mixte Rech 8525, F-59019 Lille, France
来源
PLANT CELL | 2001年 / 13卷 / 07期
关键词
D O I
10.1105/tpc.13.7.1653
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin-dependent kinase inhibitors, such as the mammalian p27(Kip1) protein, regulate correct cell cycle progression and the integration of developmental signals with the core cell cycle machinery. These inhibitors have been described in plants, but their function remains unresolved. We have isolated seven genes from Arabidopsis that encode proteins with distant sequence homology with p27(Kip1), designated Kip-related proteins (KRPs). The KRPs were characterized by their domain organization and transcript profiles, With the exception of KRP5, all presented the same cyclin-dependent kinase binding specificity. When overproduced, KRP2 dramatically inhibited cell cycle progression in leaf primordia cells without affecting the temporal pattern of cell division and differentiation. Mature transgenic leaves were serrated and consisted of enlarged cells. Although the ploidy levels in young leaves were unaffected, endoreduplication was suppressed in older leaves. We conclude that KRP2 exerts a plant growth inhibitory activity by reducing cell proliferation in leaves, but, in contrast to its mammalian counterparts, it may not control the timing of cell cycle exit and differentiation.
引用
收藏
页码:1653 / 1667
页数:15
相关论文
共 50 条
  • [1] Cyclin-dependent kinase inhibitors
    Westwell, A
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (09) : 491 - 491
  • [2] Cyclin-dependent kinase inhibitors
    Dai, Y
    Grant, S
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) : 362 - 370
  • [3] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    [J]. MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [4] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    [J]. Molecular Biotechnology, 2001, 19 : 179 - 188
  • [5] Novel cyclin-dependent kinase inhibitors
    Westwell, AD
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (13) : 701 - 701
  • [6] INHIBITORS OF CYCLIN-DEPENDENT KINASE AND CANCER
    BIGGS, JR
    KRAFT, AS
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (10): : 509 - 514
  • [7] Cyclin-dependent kinase inhibitors and hepatocarcinogenesis
    Hui, AM
    Sakamoto, M
    Kanai, Y
    Ino, Y
    Gotoh, M
    Hirohashi, S
    [J]. RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 481 - 485
  • [8] Cyclin-dependent kinase inhibitors in yeast, animals, and plants:: A functional comparison
    De Clercq, Annelies
    Inze, Dirk
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 41 (05) : 293 - 313
  • [9] Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias
    Hayette, S
    Thomas, X
    Bertrand, Y
    Tigaud, I
    Callanan, M
    Thiebaut, A
    Charrin, C
    Archimbaud, E
    Magaud, JP
    Rimokh, R
    [J]. LEUKEMIA, 1997, 11 (10) : 1696 - 1699
  • [10] Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias
    S Hayette
    X Thomas
    Y Bertrand
    I Tigaud
    M Callanan
    A Thiebaut
    C Charrin
    E Archimbaud
    J-P Magaud
    R Rimokh
    [J]. Leukemia, 1997, 11 : 1696 - 1699